Exclusive: ADC startup Mythic recruits Jazz exec to lead company; Dyne’s CEO shuffle

George Eliades

Mythic Therapeutics has gone more than a year and a half without a CEO.

That’s changing on April 1, as George Eliades will join the Waltham, MA-based antibody-drug conjugate biotech. Eliades is coming from Jazz Pharmaceuticals, where he’s served as senior vice president…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks